why am i still hungry on glp 1 you are your GLP‑1: or not hungry enough Still hungry on semaglutide? 9

We cover everything you need to know.

Learn to address challenges associated with the use of GLP-1 medications in the treatment of obesity and earn 3.75 CEUs today!

Nausea after eating is one of the most common experiences during semaglutide therapy, affecting up to 25% of users

Understanding proper dosing frequency, titration protocols, and personalized approaches helps optimize your weight management strategy

We believe in this ability to deliver real precision medicine to patients at scale for affordable prices, though prices have not yet been disclosed

In late April 2025, the FDA issued a key update regarding the use of compounded GLP-1 receptor agonists like semaglutide and tirzepatide